List of bibliographic references indexed by drugs
Number of relevant bibliographic references: 26.
[0-20] [
0 - 20][
0 - 26][
20-25][
20-40]
Ident. | Authors (with country if any) | Title |
---|
000274 (2016) |
Nadhir Litim [Canada] ; Marc Morissette [Canada] ; Thérèse Di Paolo [Canada] | Neuroactive gonadal drugs for neuroprotection in male and female models of Parkinson's disease. |
000363 (2016) |
Martin J. Brodie ; Frank Besag ; Alan B. Ettinger ; Marco Mula ; Gabriella Gobbi ; Stefano Comai ; Albert P. Aldenkamp ; Bernhard J. Steinhoff | Epilepsy, Antiepileptic Drugs, and Aggression: An Evidence-Based Review |
000519 (2015) |
Ulf Ziemann [Allemagne] ; Janine Reis [Allemagne] ; Peter Schwenkreis [Allemagne] ; Mario Rosanova [Italie] ; Antonio Strafella [Canada] ; Radwa Badawy [Australie] ; Florian Müller-Dahlhaus [Allemagne] | TMS and drugs revisited 2014. |
000750 (2015) |
Joe Kakish ; Dongsoo Lee ; Jeremy S. Lee | Drugs That Bind to α-Synuclein: Neuroprotective or Neurotoxic? |
000888 (2014) |
Omid Tavassoly [Canada] ; Joe Kakish [Canada] ; Sergiy Nokhrin [Canada] ; Oleg Dmitriev [Canada] ; Jeremy S. Lee [Canada] | The use of nanopore analysis for discovering drugs which bind to α-synuclein for treatment of Parkinson's disease. |
000941 (2014) |
Thomas J. Moore [États-Unis] ; Joseph Glenmullen [États-Unis] ; Donald R. Mattison [Canada] | Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs. |
000A70 (2014) |
Amaal Al Dakheel [Canada] ; Isabelle Beaulieu-Boire ; Susan H. Fox | Emerging drugs for levodopa-induced dyskinesia. |
000D32 (2013) |
Saranya Kittanakom [Canada] ; Anthony Arnoldo [Canada] ; Kevin R. Brown [Canada] ; Iain Wallace [Canada] ; Tada Kunavisarut [Thaïlande] ; Dax Torti [Canada] ; Lawrence E. Heisler [Canada] ; Anuradha Surendra [Canada] ; Jason Moffat [Canada] ; Guri Giaever [Canada] ; Corey Nislow [Canada] | Miniature Short Hairpin RNA Screens to Characterize Antiproliferative Drugs |
001082 (2013) |
Mee-Sook Song [Canada] ; Dmitriy Matveychuk [Canada] ; Erin M. Mackenzie [Canada] ; Maryana Duchcherer [Canada] ; Darrell D. Mousseau [Canada] ; Glen B. Baker [Canada] | An update on amine oxidase inhibitors: Multifaceted drugs |
001206 (2012) |
Russell C. Callaghan [Canada] ; James K. Cunningham ; Jenna Sykes ; Stephen J. Kish | Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs. |
001515 (2012) |
Russell C. Callaghan [Canada] ; James K. Cunningham [États-Unis] ; Jenna Sykes [Canada] ; Stephen J. Kish [Canada] | Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs |
002219 (2008) |
Jeffrey A. Lieberman ; Frank P. Bymaster ; Herbert Y. Meltzer ; Ariel Y. Deutch ; Gary E. Duncan ; Christine E. Marx ; June R. Aprille ; Donard S. Dwyer ; Xin-Min Li ; Sahebarao P. Mahadik ; Ronald S. Duman ; Joseph H. Porter ; Josephine S. Modica-Napolitano ; Samuel S. Newton ; John G. Csernansky | Antipsychotic Drugs: Comparison in Animal Models of Efficacy, Neurotransmitter Regulation, and Neuroprotection |
002733 (2006) |
A J Espay ; F. Morgante ; C. Gunraj ; R. Chen ; A E Lang | Mirror movements in Parkinson's disease: effect of dopaminergic drugs |
002B89 (2004) |
Tom H. Johnston [Canada] ; Jonathan M. Brotchie | Drugs in development for Parkinson's disease. |
002E51 (2003) |
Stanley Nattel [Canada] ; James Kneller [Canada] ; Renqiang Zou [Canada] ; L. Joshua Leon [Canada] | Mechanisms of Termination of Atrial Fibrillation by Class I Antiarrhythmic Drugs: |
002E67 (2003) |
Mahyar Etminan [Canada] ; Sudeep Gill [Canada] ; Ali Samii [États-Unis] | Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies |
003122 (2001) |
H. Moller | Antiparkinsonian drugs and "sleep attacks". |
003334 (2001) |
Moussa B. H. Youdim [Israël] ; Edna Grünblatt [Israël] ; Yona Levites-Royak [Israël] ; Silvia Mandel [Israël] | Drugs to prevent cell death in Parkinson's disease: Neuroprotection against oxidative stress and inflammatory gene expression |
003588 (2000) |
M. Cyr [Canada] ; F. Calon [Canada] ; M. Morissette [Canada] ; M. Grandbois [Canada] ; S. Callier [Canada, France] ; T. Di Paolo [Canada] | Drugs with estrogen-like potency and brain activity : Potential therapeutic application for the CNS |
003759 (1999) |
Stanley Nattel [Canada] ; Bramah N. Singh [États-Unis] | Evolution, mechanisms, and classification of antiarrhythmic drugs: focus on class III actions |
003868 (1998) |
P. Seeman [Canada] ; T. Tallerico | Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "drugs"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i \
-Sk "drugs" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= Main
|étape= Exploration
|type= indexItem
|index= Title.i
|clé= drugs
}}
| This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022 | |